The Gross Margin of Staidson Beijing BioPharmaceuticals Co Ltd (300204.SZ) is 80.83%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 80.83% |
| 2023-12-31 | 79.52% |
| 2022-12-31 | 81.46% |
| 2021-12-31 | 80.07% |
| 2020-12-31 | 81.75% |
| 2019-12-31 | 87.77% |
| 2018-12-31 | 90.72% |
| 2017-12-31 | 94.45% |
| 2016-12-31 | 94.97% |
| 2015-12-31 | 94.57% |